U.S. Markets close in 4 hrs 50 mins

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.62+0.07 (+1.97%)
As of 11:09AM EDT. Market open.
People also watch
ACHNALNYMACKIDRAFOLD
Full screen
Previous Close3.55
Open3.60
Bid3.63 x 600
Ask3.64 x 500
Day's Range3.58 - 3.79
52 Week Range1.20 - 8.09
Volume485,129
Avg. Volume1,128,171
Market Cap270.68M
Beta0.78
PE Ratio (TTM)-5.64
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Here's What Caused Arrowhead Pharmaceuticals' Stock to Spike Today
    Motley Fool10 days ago

    Here's What Caused Arrowhead Pharmaceuticals' Stock to Spike Today

    The announcement of a new RNAi drug-development platform has traders feeling a bit giddy about the clinical-stage biotech.

  • Capital Cube14 days ago

    ETFs with exposure to Arrowhead Pharmaceuticals, Inc. : September 12, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Arrowhead Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to ARWR-US. Comparing the performance and risk of Arrowhead Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q3, 2017 By the Numbers : September 8, 2017
    Capital Cube17 days ago

    Arrowhead Pharmaceuticals, Inc. :ARWR-US: Earnings Analysis: Q3, 2017 By the Numbers : September 8, 2017

    Categories: Yahoo FinanceGet free summary analysis Arrowhead Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Arrowhead Pharmaceuticals, Inc. – Alnylam Pharmaceuticals, Inc, Ionis Pharmaceuticals, Inc., Johnson & Johnson, Shire PLC Sponsored ADR, Ligand Pharmaceuticals Incorporated, Nanophase Technologies Corporation, Inovio Pharmaceuticals, Inc., Abeona Therapeutics, ... Read more (Read more...)